You have 9 free searches left this month | for more free features.

Lenalidomide

Showing 1 - 25 of 1,173

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Marginal Zone Lymphoma Trial (Mosunetuzumab + Lenalidomide, - Rituximab + Lenalidomide (28-days cycles, - Rituximab +

Not yet recruiting
  • Marginal Zone Lymphoma
  • Mosunetuzumab + Lenalidomide
  • +3 more
  • (no location specified)
Aug 16, 2023

Relapsed/Refractory Follicular Lymphoma, Marginal Zone Lymphoma (MZL) Trial in Chiang Mai (Odronextamab, Lenalidomide,

Recruiting
  • Relapsed/Refractory Follicular Lymphoma
  • Marginal Zone Lymphoma (MZL)
  • Chiang Mai, Thailand
    Chiang Mai University
Nov 20, 2023

Multiple Myeloma Trial in Canton (Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Lenalidomide
  • Canton, Ohio
    Gabrail Cancer & Research Center
Oct 11, 2023

MDS Trial in Beijing (Lenalidomide, Azacitidine)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Beijing, China
    Peking union medical college hospital
Aug 16, 2023

Selinexor Combined With Lenalidomide and Rituximab in Treatment

Not yet recruiting
  • Lymphoma, Large B-Cell, Diffuse
  • Selinexor combined with lenalidomide and rituximab
  • Shanghai, China
    Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
Jun 20, 2023

Multiple Myeloma, Myeloma-Associated Amyloidosis Trial in Saint Louis (Selinexor, Lenalidomide, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • Myeloma-Associated Amyloidosis
  • Saint Louis, Missouri
    Washington University School of Medicine
Apr 6, 2023

Multiple Myeloma Trial in Houston (Isatuximab, lenalidomide)

Not yet recruiting
  • Multiple Myeloma
  • Houston, Texas
    M D Anderson Cancer Center
Mar 8, 2023

Based on Quantitative Pharmacology in Patients With Lenalidomide

Recruiting
  • Multiple Myeloma
  • +2 more
    • Jinan, Shandong, China
      the First Affiliated Hospital of Shandong First Medical Universi
    Oct 3, 2023

    Tafasitamab in Combination With Lenalidomide in Patients withR/R

    Not yet recruiting
    • Diffuse Large B-cell Lymphoma
    • Tafasitamab Injection
    • Shanghai, China
      Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
    May 31, 2023

    Advanced HCC Trial (Lenalidomide)

    Not yet recruiting
    • Advanced HCC
    • Lenalidomide
    • (no location specified)
    Apr 16, 2023

    Marginal Zone Lymphoma Trial in Tianjin (Obinutuzumab, lenalidomide)

    Recruiting
    • Marginal Zone Lymphoma
    • Obinutuzumab, lenalidomide
    • Tianjin, Tian, China
      Institute of Hematology & Blood Diseases Hospital
    Apr 27, 2023

    B-cell Non-Hodgkin's Lymphoma Trial (IMM0306, Lenalidomide capsule)

    Not yet recruiting
    • B-cell Non-Hodgkin's Lymphoma
    • (no location specified)
    Mar 6, 2023

    DLBCL - Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in Xiamen (Lenalidomide combined with G-CHOP (LO CHOP))

    Recruiting
    • DLBCL - Diffuse Large B Cell Lymphoma
    • Follicular Lymphoma
    • Lenalidomide combined with G-CHOP (LO CHOP)
    • Xiamen, Fujian, China
      Bing Xu
    Nov 28, 2023

    Multiple Myeloma Trial in Rennes (Blood and bone marrow sampling)

    Completed
    • Multiple Myeloma
    • Blood and bone marrow sampling
    • Rennes, France
      CHU Rennes
    Feb 2, 2023

    Multiple Myeloma, Cancer, Hematologic Cancer Trial in Cork (Discontinuation of maintenance treatment)

    Not yet recruiting
    • Multiple Myeloma
    • +2 more
    • Discontinuation of maintenance treatment
    • Cork, Ireland
      Cork University Hospital
    May 10, 2023

    Diffuse Large B Cell Lymphoma Trial (Epcoritamab, Lenalidomide)

    Not yet recruiting
    • Diffuse Large B Cell Lymphoma
    • Epcoritamab
    • Lenalidomide
    • (no location specified)
    Jan 20, 2023

    Diffuse Large B Cell Lymphoma | DLBCL Recurrent/Refractory Trial (ZR2-ICE)

    Not yet recruiting
    • Diffuse Large B Cell Lymphoma | Diffuse Large B-Cell Lymphoma Recurrent/Refractory
    • (no location specified)
    Sep 5, 2023

    Multiple Myeloma Trial in Worldwide (Elranatamab, Daratumumab, Lenalidomide)

    Recruiting
    • Multiple Myeloma
    • Nagaizumi-cho,Sunto-gun, Shizuoka, Japan
    • +7 more
    Jan 9, 2023

    Oral Ulcer Trial in Beijing (Lenalidomide 10 mg)

    Not yet recruiting
    • Oral Ulcer
    • Lenalidomide 10 mg
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Jul 5, 2022

    Non-Hodgkin Lymphoma Trial in Cologne (Tafasitamab, Lenalidomide, Rituximab)

    Not yet recruiting
    • Non-Hodgkin Lymphoma
    • Cologne, Germany
      University of Cologne
    Oct 14, 2022

    Lymphoma Trial in Houston (Rituximab, Lenalidomide, Valemetostat)

    Not yet recruiting
    • Lymphoma
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 4, 2023

    Multiple Myeloma Trial in Augusta (Lenalidomide, Vitamin D - Intensified, Vitamin D - Therapeutic)

    Not yet recruiting
    • Multiple Myeloma
    • Lenalidomide
    • +2 more
    • Augusta, Georgia
      Georgia Cancer Center at Augusta University
    Apr 26, 2023

    Obinutuzumab in Combination With Lenalidomide in Relapsed or

    Recruiting
    • Follicular Lymphoma
      • Tianjin, China
        Institute of Hematology and Blood Diseases Hospital ,Chinese Aca
      Apr 27, 2023

      Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Tampa (High Dose Methylprednisolone (HDMP), Ofatumumab,

      Active, not recruiting
      • Chronic Lymphocytic Leukemia
      • Small Lymphocytic Lymphoma
      • High Dose Methylprednisolone (HDMP)
      • +2 more
      • Tampa, Florida
        H. Lee Moffitt Cancer Center and Research Institute
      Jan 12, 2023

      Hodgkin Lymphoma, B-Cell Lymphoma, Relapsed B-cell NHL Trial in Houston (Mosunetuzumab, Polatuzumab vedotin, Tafasitamab)

      Not yet recruiting
      • Hodgkin Lymphoma
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Nov 7, 2022